Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

The Blood-brain Barrier00:49

The Blood-brain Barrier

47.3K
Overview
47.3K
Regulation of Angiogenesis and Blood Supply01:24

Regulation of Angiogenesis and Blood Supply

2.9K
Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits.  Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...
2.9K
Anticoagulant Drugs: Low-Molecular-Weight Heparins01:30

Anticoagulant Drugs: Low-Molecular-Weight Heparins

2.6K
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
2.6K
Treatment for Pulmonary Arterial Hypertension: Phosphodiesterase Inhibitors01:28

Treatment for Pulmonary Arterial Hypertension: Phosphodiesterase Inhibitors

823
Phosphodiesterase 5 (PDE5) inhibitors are potent enzymes that function to hydrolyze cyclic nucleotides to their corresponding 5' monophosphates. Their unique biochemical properties have been applied in treating Pulmonary Arterial Hypertension (PAH).
Among the PDE5 inhibitors, sildenafil (Revatio) stands out as a competitive and selective inhibitor. It operates by elevating cellular levels of cGMP and augmenting signaling through the cGMP-PKG pathway, promoting vasodilation. Upon oral...
823
Treatment for Pulmonary Arterial Hypertension: Endothelin Receptor Antagonists01:18

Treatment for Pulmonary Arterial Hypertension: Endothelin Receptor Antagonists

615
Endothelins (ETs) are potent vasoactive peptides critical in the human body's various physiological and pathological processes. One of the most promising therapeutic strategies for treating pulmonary arterial hypertension (PAH) involves counteracting the effects of these endothelins using a class of drugs known as endothelin receptor antagonists.
ETs are synthesized through a complex sequence of enzymatic steps, primarily involving an enzyme referred to as endothelin-converting enzyme...
615
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

765
Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
765

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The role of species interactions in shaping the geographic pattern of ungulate abundance across African savannah.

Scientific reports·2024
Same author

Is the sarcomatous component (homologous vs heterologous) the prognostic "driving force" in early-stage uterine carcinosarcomas? A retrospective multicenter study.

Journal of cancer research and clinical oncology·2023
Same author

Surgical outcomes of diaphragmatic resection during cytoreductive surgery for advanced gynecological ovarian neoplasia: A randomized single center clinical trial - DRAGON.

Gynecologic oncology·2021
Same author

Impact of surgeon learning curve in minimally invasive radical hysterectomy on early stage cervical cancer patient survival.

Facts, views & vision in ObGyn·2021
Same author

Minimally Invasive Approaches in Locally Advanced Cervical Cancer Patients Undergoing Radical Surgery After Chemoradiotherapy: A Propensity Score Analysis.

Annals of surgical oncology·2020
Same author

Total laparoscopic hysterectomy for enlarged uteri: factors associated with the rate of conversion to open surgery.

Journal of obstetrics and gynaecology : the journal of the Institute of Obstetrics and Gynaecology·2019

Related Experiment Video

Updated: May 5, 2026

Assessing Endothelial Vasodilator Function with the Endo-PAT 2000
07:46

Assessing Endothelial Vasodilator Function with the Endo-PAT 2000

Published on: October 16, 2010

45.2K

Tetrahydrobiopterin and endothelial function

F Cosentino1, T F Lüscher

  • 1University Hospital and Cardiovascular Research, Institute of Physiology, Zürich, Switzerland.

European Heart Journal
|August 26, 1998
PubMed
Summary
This summary is machine-generated.

Tetrahydrobiopterin (BH4) is crucial for nitric oxide synthase (NOS) function. BH4 deficiency impairs nitric oxide production, contributing to endothelial dysfunction and vascular diseases like atherosclerosis.

More Related Videos

Ultrasound Assessment of Endothelial-Dependent Flow-Mediated Vasodilation of the Brachial Artery in Clinical Research
08:42

Ultrasound Assessment of Endothelial-Dependent Flow-Mediated Vasodilation of the Brachial Artery in Clinical Research

Published on: October 22, 2014

26.8K
Evaluation of Bioenergetic Function in Cerebral Vascular Endothelial Cells
06:15

Evaluation of Bioenergetic Function in Cerebral Vascular Endothelial Cells

Published on: November 19, 2016

10.6K

Related Experiment Videos

Last Updated: May 5, 2026

Assessing Endothelial Vasodilator Function with the Endo-PAT 2000
07:46

Assessing Endothelial Vasodilator Function with the Endo-PAT 2000

Published on: October 16, 2010

45.2K
Ultrasound Assessment of Endothelial-Dependent Flow-Mediated Vasodilation of the Brachial Artery in Clinical Research
08:42

Ultrasound Assessment of Endothelial-Dependent Flow-Mediated Vasodilation of the Brachial Artery in Clinical Research

Published on: October 22, 2014

26.8K
Evaluation of Bioenergetic Function in Cerebral Vascular Endothelial Cells
06:15

Evaluation of Bioenergetic Function in Cerebral Vascular Endothelial Cells

Published on: November 19, 2016

10.6K

Area of Science:

  • Biochemistry
  • Vascular Biology
  • Pharmacology

Background:

  • Tetrahydrobiopterin (BH4) is an essential co-factor for nitric oxide synthases (NOS).
  • A link between BH4 and nitric oxide (NO) synthesis is established in various cell types, including endothelial cells.
  • The exact regulatory role of BH4 in NOS activity, potentially as an allosteric and redox co-factor, is under investigation.

Purpose of the Study:

  • To review the intricate relationship between tetrahydrobiopterin and nitric oxide synthase.
  • To elucidate the role of BH4 in regulating vascular tone and NO production.
  • To explore the implications of BH4 deficiency in endothelial dysfunction and vascular diseases.

Main Methods:

  • Literature review of studies investigating BH4 and NOS interactions.
  • Analysis of experimental data on BH4 administration and depletion in arterial models.
  • Synthesis of evidence linking BH4 to NO synthesis and vascular health.

Main Results:

  • Administration of BH4 stimulates NO production in peripheral and cerebral arteries.
  • Arteries depleted of BH4 exhibit impaired nitric oxide synthesis.
  • Decreased BH4 availability under pathological conditions can lead to NOS dysfunction.

Conclusions:

  • BH4 plays a critical role in maintaining adequate nitric oxide production by NOS.
  • BH4 deficiency contributes to an imbalance favoring oxidative stress over protective NO signaling.
  • Understanding the BH4-NOS interaction is key to addressing endothelial dysfunction in vascular diseases such as atherosclerosis.